Merck (MRK), Lilly (LLY) Enter Collaboration for KEYTRUDA Combo
Tweet Send to a Friend
Merck (NYSE: MRK) and Eli Lilly and Company (NYSE: LLY) announced an oncology clinical trial collaboration to evaluate the safety ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE